List Title | APhA DrugInfoLine

Neurology

SORT BY: Most Recent Most Viewed

September 9, 2015

Investigational herpes zoster vaccine effective in older adults

READ

PREVIEW
Administration of an investigational inactivated herpes zoster vaccine, known as the HZ/su vaccine, in a large Phase III trial showed that the vaccine had efficacy rates of 96.6% and 97.9% for...
May 20, 2015

Folic acid: Option for primary stroke prevention

READ

PREVIEW
Adding folic acid to enalapril in patients with hypertension reduced the risk of first stroke compared with enalapril alone, according to results of the China Stroke Primary Prevention Trial...
February 24, 2015

Neuropathic pain: Analysis sheds light on best treatments

READ

PREVIEW
Evidence supports the use of tricyclic antidepressants, serotonin–noradrenaline reuptake inhibitors, pregabalin, and gabapentin as first-line agents for the management of patients with...
November 3, 2014

More than half of nursing home residents with dementia take unnecessary medications

READ

PREVIEW
More than half of nursing home residents with advanced dementia receive medications of questionable benefit with costly consequences, according to results of a recent study.
August 19, 2014

Levodopa phobia? Study shows fears unfounded

READ

PREVIEW
Choice of initial therapy with either a dopamine agonist, levodopa, or monoamine oxidase (MAO) type B inhibitor in patients with early Parkinson’s disease (PD) results in similar patient-rated...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.